Ticarcillin/Clavulanate Uses

How old is patient?
sponsored

Consists of Clavulanate, Ticarcillin

Clavulanate (Ticarcillin/Clavulanate) indications

sponsored

For use with Amoxicillin, clavulanic acid is suitable for the treatment of infections with Staph. aureus and Bacteroides fragilis, or with beta-lactamase producing H. influenzae and E. coli. (Bacterial infection;)

Clavulanate (Ticarcillin/Clavulanate) description

Clavulanic acid and its salts and esters. The acid is a suicide inhibitor of bacterial beta-lactamase enzymes from Streptomyces clavuligerus. Administered alone, it has only weak antibacterial activity against most organisms, but given in combination with beta-lactam antibiotics prevents antibiotic inactivation by microbial lactamase. [PubChem]

What is Ticarcillin (Ticarcillin/Clavulanate)?

Ticarcillin (Ticarcillin/Clavulanate) is an antibiotic in a group of drugs called penicillins. Ticarcillin (Ticarcillin/Clavulanate) fights bacteria in the body.

The combination of Ticarcillin (Ticarcillin/Clavulanate) is used to treat many different infections caused by bacteria, such as urinary tract infections, bone and joint infections, severe vaginal infections, stomach infections, and skin infections.

Ticarcillin (Ticarcillin/Clavulanate) may also be used for purposes other than those listed in this medication guide.

Ticarcillin (Ticarcillin/Clavulanate) indications

Intravenous

Severe Gram-negative infections; Skin infections; Septicaemia; Peritonitis; Bone and joint infections

Adult: 200-300 mg/kg daily by infusion in divided doses every 4 or 6 hr.

Child: 200-300 mg/kg by infusion in divided doses every 4 or 6 hr.

Renal impairment: Peritoneal dialysis patients: 3 g every 12 hr; haemodialysis patients: 2 g every 12 hr plus an additional dose of 3 g after each dialysis session.

CrCl (ml/min)Dosage Recommendation
30-60Initial IV loading dose of 3 g, followed by 2 g every 4 hr.
10-30Initial IV loading dose of 3 g, followed by 2 g every 8 hr.
<10Initial IV loading dose of 3 g, followed by 2 g every 12 hr (or 1 g IM every 6 hr).
<10> with hepatic impairmentInitial IV loading dose of 3 g, followed by 2 g IV every 24 hr or 1 g IM every 12 hr.

Incompatibility: Incompatible with aminoglycosides.

Parenteral

Uncomplicated urinary tract infections

Adult: 1 g IM/slow IV Inj every 6 hr.

Child: 50-100 mg/kg in divided doses every 6-8 hr. Do not inject >2 g into each IM site.

Incompatibility: Incompatible with aminoglycosides.

Parenteral

Complicated urinary tract infections

Adult: 150-200 mg/kg daily by IV infusion in divided doses every 4 or 6 hr.

Child: 150-200 mg/kg daily by IV infusion in divided doses every 4 or 6 hr.

Renal impairment: Peritoneal dialysis patients: 3 g every 12 hr; haemodialysis patients: 2 g every 12 hr plus an additional dose of 3 g after each dialysis session.

CrCl (ml/min)Dosage Recommendation
30-60Initial IV loading dose of 3 g, followed by 2 g every 4 hr.
10-30Initial IV loading dose of 3 g, followed by 2 g every 8 hr.
<10Initial IV loading dose of 3 g, followed by 2 g every 12 hr (or 1 g IM every 6 hr).
<10 with hepatic impairmentInitial IV loading dose of 3 g, followed by 2 g IV every 24 hr or 1 g IM every 12 hr.

Incompatibility: Incompatible with aminoglycosides.

How should I use Ticarcillin (Ticarcillin/Clavulanate)?

Use Ticarcillin (Ticarcillin/Clavulanate) as directed by your doctor. Check the label on the medicine for exact dosing instructions.

Ask your health care provider any questions you may have about how to use Ticarcillin (Ticarcillin/Clavulanate).

Uses of Ticarcillin (Ticarcillin/Clavulanate) in details

sponsored

Ticarcillin (Ticarcillin/Clavulanate) is used (in combination with clavulanic acid) in the treatment of various bacterial infections involving bones, joints, skin and soft tissue, respiratory tract, ear, nose and throat, kidney and other parts of the body.

Ticarcillin (Ticarcillin/Clavulanate) description

An antibiotic derived from penicillin similar to carbenicillin in action.

Ticarcillin (Ticarcillin/Clavulanate) dosage

Ticarcillin (Ticarcillin/Clavulanate) Dosage

Applies to the following strengths: 1 g; 3 g; 20 g; 30 g

Usual Adult Dose for:

Usual Pediatric Dose for:

Additional dosage information:

Usual Adult Dose for Febrile Neutropenia

3 g IV every 4 hours. Therapy should be continued for approximately 14 days, or until more specific therapy may be substituted for a proven infection, or until the patient has been afebrile for 24 hours after the absolute neutrophil count has been greater than 500 cells/mm3.

Ticarcillin (Ticarcillin/Clavulanate) should be used in combination with another anti-infective agent, usually an aminoglycoside, for the empiric treatment of febrile patients.

Usual Adult Dose for Intraabdominal Infection

3 g IV every 4 hours, for 7 to 14 days depending on the nature and severity of the infection.

Usual Adult Dose for Joint Infection

3 g IV every 4 hours for up to 3 or 4 weeks, depending on the nature and severity of the infection. Longer therapy, sometimes up to 6 weeks, may be necessary for prosthetic joint infections.

Usual Adult Dose for Osteomyelitis

3 g IV every 4 hours. Therapy should be continued for 4 to 6 weeks. Chronic osteomyelitis may require additional oral antimicrobial therapy, possibly up to 6 months.

Usual Adult Dose for Pelvic Inflammatory Disease

3 g IV every 4 to 6 hours.

Parenteral therapy should continue for 48 hours after clinical improvement is observed, at which time oral therapy may be initiated and continued for a total of 14 days of treatment.

If the patient is not pregnant, appropriate treatment for possible chlamydia infection should be initiated and any sexual partner(s) should be evaluated.

The Centers for Disease Control and Prevention currently recommend cefotetan or cefoxitin plus doxycycline, or clindamycin plus gentamicin for the treatment of pelvic inflammatory disease.

Usual Adult Dose for Peritonitis

3 g IV every 4 hours. Ticarcillin (Ticarcillin/Clavulanate) is generally used as part of combination therapy when treating peritonitis. Therapy should be continued for approximately 10 to 14 days.

Intraperitoneal cefazolin plus ceftazidime are recommended for treatment of peritoneal dialysis-associated peritonitis.

Usual Adult Dose for Pneumonia

3 g IV every 4 hours for 21 to 28 days, depending on the nature and severity of the infection.

Usual Adult Dose for Pyelonephritis

3 g IV every 4 to 6 hours for 14 days, depending on the nature and severity of the infection.

Usual Adult Dose for Septicemia

3 g IV every 4 hours for 14 days, depending on the nature and severity of the infection.

Usual Adult Dose for Skin or Soft Tissue Infection

3 g IV every 4 hours for 7 to 10 days, or for 3 days after acute inflammation resolves, depending on the nature and severity of the infection.

Usual Adult Dose for Urinary Tract Infection

Complicated: 3 g IV every 4 to 6 hours for 14 days, depending on the nature and severity of the infection.

Uncomplicated: 1 g IM or IV every 6 hours

Usual Pediatric Dose for Intraabdominal Infection

Neonates:

< 7 days, birthweight < 2000 g: 75 mg/kg IV every 12 hours

< 7 days, birthweight > 2000 g: 75 mg/kg IV every 8 hours

> 7 days, birthweight < 1200 g: 75 mg/kg every 12 hours

> 7 days, birthweight < 2000 g: 75 mg/kg IV every 8 hours

> 7 days, birthweight > 2000 g: 75 mg/kg every 6 hours or 100 mg/kg IV every 8 hours

1 month to 12 years:

< 40 kg: 100 to 300 mg/kg/day IV in equally divided doses every 4 to 6 hours

> 40 kg: Adult dose

Usual Pediatric Dose for Pneumonia

Neonates:

< 7 days, birthweight < 2000 g: 75 mg/kg IV every 12 hours

< 7 days, birthweight > 2000 g: 75 mg/kg IV every 8 hours

> 7 days, birthweight < 1200 g: 75 mg/kg every 12 hours

> 7 days, birthweight < 2000 g: 75 mg/kg IV every 8 hours

> 7 days, birthweight > 2000 g: 75 mg/kg every 6 hours or 100 mg/kg IV every 8 hours

1 month to 12 years:

< 40 kg: 100 to 300 mg/kg/day IV in equally divided doses every 4 to 6 hours

> 40 kg: Adult dose

Usual Pediatric Dose for Skin or Soft Tissue Infection

Neonates:

< 7 days, birthweight < 2000 g: 75 mg/kg IV every 12 hours

< 7 days, birthweight > 2000 g: 75 mg/kg IV every 8 hours

> 7 days, birthweight < 1200 g: 75 mg/kg every 12 hours

> 7 days, birthweight < 2000 g: 75 mg/kg IV every 8 hours

> 7 days, birthweight > 2000 g: 75 mg/kg every 6 hours or 100 mg/kg IV every 8 hours

1 month to 12 years:

< 40 kg: 100 to 300 mg/kg/day IV in equally divided doses every 4 to 6 hours

> 40 kg: Adult dose

Usual Pediatric Dose for Septicemia

Neonates:

< 7 days, birthweight < 2000 g: 75 mg/kg IV every 12 hours

< 7 days, birthweight > 2000 g: 75 mg/kg IV every 8 hours

> 7 days, birthweight < 1200 g: 75 mg/kg every 12 hours

> 7 days, birthweight < 2000 g: 75 mg/kg IV every 8 hours

> 7 days, birthweight > 2000 g: 75 mg/kg every 6 hours or 100 mg/kg IV every 8 hours

1 month to 12 years:

< 40 kg: 200 to 300 mg/kg/day IV in equally divided doses every 4 to 6 hours

> 40 kg: Adult dose

Usual Pediatric Dose for Urinary Tract Infection

Uncomplicated infections:

1 month to 12 years:

< 40 kg: 50 to 100 mg/kg/day IV or IM in equally divided doses every 6 to 8 hours.

> 40 kg: Adult dose.

Complicated infections:

1 month to 12 years:

< 40 kg: 150 to 200 mg/kg/day IV in equally divided doses every 4 to 6 hours.

> 40 kg: Adult dose.

Renal Dose Adjustments

Adults:

CrCl < 10 mL/min: Initial loading dose of 3 g followed by 2 g IV every 12 hours or 1 g IM every 6 hours.

CrCl 10 to 30 mL/min: Initial loading dose of 3 g followed by 2 g IV every 8 hours.

CrCl 30 to 60 mL/min: Initial loading dose of 3 g followed by 2 g IV every 4 hours.

Liver Dose Adjustments

Adults:

Hepatic dysfunction and CrCl < 10 mL/min: 3 g IV once as a loading dose, followed by 2 g IV every 24 hours.

Dose Adjustments

Doses as high as 400 mg/kg/day IV equally divided every 4 to 6 hours have been used to treat acute pulmonary exacerbations of cystic fibrosis.

Dialysis

Adults:

Hemodialysis: 3 g IV once as a loading dose, followed by 2 g IV every 12 hours supplemented with 3 g after each dialysis.

Peritoneal dialysis: 3 g IV every 12 hours

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

More about Ticarcillin (Ticarcillin/Clavulanate)

Professional resources

Related treatment guides

Ticarcillin (Ticarcillin/Clavulanate) interactions

See also:
What other drugs will affect Ticarcillin (Ticarcillin/Clavulanate)?

sponsored

Probenecid decreases clearance of Ticarcillin (Ticarcillin/Clavulanate). Increased bleeding risk with warfarin, acenocoumarol. Possible increase in ciclosporin, methotrexate levels with concurrent use. Possible contraceptive failure with combined oral contraceptives.

Ticarcillin (Ticarcillin/Clavulanate) side effects

See also:
What are the possible side effects of Ticarcillin (Ticarcillin/Clavulanate)?

Pain at the inj site and phlebitis; electrolyte disturbances (hypokalaemia or hypernatraemia); dose-dependent coagulation defect; purpura and haemorrhage; hypersensitivity reactions; haemolytic anaemia; interstitial nephritis; neutropenia; CNS toxicity including convulsions; diarrhoea; pseudomembranous colitis. Haemorrhagic cystitis especially in cystic fibrosis patients.

Potentially Fatal: Anaphylaxis.

Ticarcillin (Ticarcillin/Clavulanate) contraindications

See also:
What is the most important information I should know about Ticarcillin (Ticarcillin/Clavulanate)?

Hypersensitivity to penicillins.

Active ingredient matches for Ticarcillin/Clavulanate:

Clavulanate/Ticarcillin


List of Ticarcillin/Clavulanate substitutes (brand and generic names)

Sort by popularity
Unit description / dosage (Manufacturer)Price, USD

References

  1. PubChem. "TICARCILLIN". https://pubchem.ncbi.nlm.nih.gov/com... (accessed September 17, 2018).
  2. DrugBank. "TICARCILLIN". http://www.drugbank.ca/drugs/DB01607 (accessed September 17, 2018).
  3. MeSH. "Anti-Bacterial Agents". https://www.ncbi.nlm.nih.gov/mesh/68... (accessed September 17, 2018).

Reviews

The results of a survey conducted on ndrugs.com for Ticarcillin/Clavulanate are given in detail below. The results of the survey conducted are based on the impressions and views of the website users and consumers taking Ticarcillin/Clavulanate. We implore you to kindly base your medical condition or therapeutic choices on the result or test conducted by a physician or licensed medical practitioners.

User reports

Consumer reported useful

No survey data has been collected yet


Consumer reported price estimates

No survey data has been collected yet


Consumer reported time for results

No survey data has been collected yet


Consumer reported age

No survey data has been collected yet


Consumer reviews


There are no reviews yet. Be the first to write one!


Your name: 
Email: 
Spam protection:  < Type 16 here

Information checked by Dr. Sachin Kumar, MD Pharmacology

| Privacy Policy
This site does not supply any medicines. It contains prices for information purposes only.
© 2003 - 2024 ndrugs.com All Rights Reserved